All Stories

  1. New and emerging immune-targeted drugs for the treatment of multiple sclerosis

    Article • British Journal of Clinical Pharmacology, June 2014, Wiley

    Professor Alan Palmer

  2. The utility of biomarkers in CNS drug development

    Article • Drug Discovery Today, March 2014, Elsevier

    Professor Alan Palmer

  3. Overview of Experimental Models of the Blood‐Brain Barrier in CNS Drug Discovery

    Article • Current Protocols in Pharmacology, October 2013, Wiley

    Professor Alan Palmer

  4. Translational medicines research

    Article • Drug Discovery Today, June 2013, Elsevier

    Professor Alan Palmer

  5. What are the prospects of slowing the progression of Alzheimer's disease?

    Article • Drug Discovery Today, November 2012, Elsevier

    Professor Alan Palmer

  6. Translational CNS medicines research

    Article • Drug Discovery Today, October 2012, Elsevier

    Professor Alan Palmer

  7. Pharmacotherapeuetic Options for the Treatment of Multiple Sclerosis

    Article • Clinical Medicine Insights Therapeutics, June 2012, Libertas Academica, Ltd.

    Professor Alan Palmer

  8. Neuroprotective therapeutics for Alzheimer's disease: progress and prospects

    Article • Trends in Pharmacological Sciences, March 2011, Elsevier

    Professor Alan Palmer

  9. Measurement of the pharmacokinetics and pharmacodynamics of neuroactive compounds

    Article • Neurobiology of Disease, January 2010, Elsevier

    Professor Alan Palmer

  10. Neurochemistry of Aging

    Article • Wiley

    Professor Alan Palmer